BRD IS AN RBD
BRD is an RBD (really big deal) and a big challenge. Commonly known as shipping fever or pneumonia, BRD is one of the most pervasive diseases in the cattle industry. Learn how you can prevent, control and treat BRD with Elanco.
Breathe Easier. We've got you covered.
Unpredictable weather, nutritional challenges and transportation stress on your herd may not always be in the realm of your control. But the cost to cattle producers — about $1 billion annually1 — doesn't go unnoticed. With our portfolio that is 40 years in the making, you can choose what tools you use to control and treat BRD in your herd.
BRD-causing pathogens are both viral and bacterial. Vaccination that protects against both is an important part of a BRD-prevention strategy that prepares each animal's immune system.
Elanco BRD vaccines help protect against the leading causes of BRD so cattle stay healthy and productive.
NUPLURA® PH and NUPLURA PH+
NUPLURA PH gives the fastest protection in as few as 10 days against Mannheimia haemolytica — the bacterial pathogen responsible for most cases of BRD.² NUPLURA PH+ combines the protection of NUPLURA PH and Titanium® in one vaccine, giving herds fast, smooth and powerful protection against Mannheimia haemolytica, BVD Type 1 and 2 and IBR — leading causes of BRD.
Provides important protection as a modified live virus (MLV) vaccine against up to 10 respiratory and reproductive pathogens. Used as the foundation of a vaccine program for lifetime immunity, trust Titanium to set your herd up for protection without post-vaccinal stress.*³,⁴
Delivers Control Without Complication® against up to 13 respiratory and reproductive pathogens. Stress less with Vira Shield as it doesn’t negatively impact reproductive rates so you can see more calves and fewer open animals.⁵
Offers a unique combination of protection against 11 respiratory and reproductive pathogens through both inactivated and MLV antigens to provide respiratory and reproductive protection for your herd — including pregnant cows.
FOR ALL PRODUCTS: The label contains complete use information, including cautions and warnings. Always read, understand and follow the label, and use directions.
Not for animals intended for breeding.
Micotil is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, and for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica.
IMPORTANT SAFETY INFORMATION:
Before using this product, it is important to read the entire product insert, including the boxed human warning. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for human use. Injection of this drug in humans has been associated with fatalities. Keep out of reach of children. Administer only with a tube-fed safety syringe. Do not use in automatically powered syringes, single-use syringes, or other delivery devices. Exercise extreme caution to avoid accidental self-injection. In case of human injection, consult a physician immediately and apply ice or cold pack to injection site while avoiding direct contact with the skin. Avoid contact with eyes. Always use proper drug handling procedures to avoid accidental self-injection. Consult your veterinarian on the safe handling and use of all injectable products prior to administration. For use in cattle or sheep only. Inject subcutaneously. Injection of this antibiotic has been shown to be fatal in swine and non-human primates, and may be fatal in horses and goats. Do not use in lambs less than 15 kg body weight. Do not use in female dairy cattle 20 months of age or older. Use in lactating dairy cattle or sheep may cause milk residues. The following adverse reactions have been reported: in cattle: injection site swelling and inflammation, lameness, collapse, anaphylaxis/anaphylactoid reactions, decreased food and water consumption, and death; in sheep: dyspnea and death. Micotil has a pre-slaughter withdrawal time of 42 days.
Not for human use. Keep out of reach of children. For subcutaneous use in beef cattle and non-lactating dairy cattle.
Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. Federal (U.S.A.) law prohibits the extra-label use of this drug in food-producing animals.
Cattle – Single-Dose Therapy: Baytril 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.
Cattle – Multiple-Day Therapy: Baytril 100 is indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle.
Directions for use:
Single-Dose Therapy (BRD Treatment): Administer, by subcutaneous injection, a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lbs.).
Multiple-Day Therapy (BRD Treatment): Administer daily, a subcutaneous dose of 2.5-5 mg/kg of body weight (1.1-2.3 mL/100 lbs.).
Treatment should be repeated at 24-hour intervals for three days. Additional treatments may be given on days 4 and 5 to animals that have shown clinical improvement but not total recovery.
Baytril 100 provides flexible subcutaneous injection dosages and durations of therapy.
Do not use in female dairy cattle 20 months of age or older or in calves to be processed for veal.
Talk with your veterinarian to learn more.
Beef and Non-Lactating Dairy Cattle: Treatment of bovine respiratory disease (BRD)
and control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis. Treatment of infectious bovine
keratoconjunctivitis (IBK) associated with M. bovis. Treatment of bovine foot rot (interdigital necrobacillosis) associated with F. necrophorum and P. levii.
Suckling Calves, Dairy Calves and Veal Calves: Treatment of BRD associated with M.
haemolytica, P. multocida, H. somni and M. bovis.
IMPORTANT SAFETY INFORMATION (ISI):
Not for human use. Keep out of reach of children. Do not use in animals previously found to be hypersensitive to the drug. Increxxa has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Loncor 300 is indicated for treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, and for the treatment of bovine interdigital phlegmon (foot rot, acute interdigital necrobacillosis, infectious pododermatitis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus. Also, it is indicated for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni.
Do not use Titanium® BRSV 3, Titanium® 3 LP, Titanium® 3, Titanium® IBR LP and Titanium® IBR in pregnant cows or in calves nursing pregnant cows. Abortions may result.
Increxxa, Master Guard, Micotil, Nuplura Titanium, Tylan, Vira Shield, Zelnate, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
Baytril and Loncor are sold by Elanco or its affiliates and are not Bayer products. The Baytril and Loncor trademarks are owned by Bayer and used under license.
Click to download Baytril 100 Product Label.